Skip to main
VCEL
VCEL logo

Vericel (VCEL) Stock Forecast & Price Target

Vericel (VCEL) Analyst Ratings

Based on 9 analyst ratings
Strong Buy
Strong Buy 56%
Buy 44%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Vericel Corp's burn care franchise demonstrated strong performance with a 22% year-over-year growth, reaching $39.9 million in FY2024, driven by an expanded salesforce expected to sustain high single-digit growth in 2025. The company reported MACI revenue of $68.3 million in the fourth quarter of FY2024, marking a 21% increase year-over-year, showcasing its robust product pipeline with anticipated new launches, which are expected to further enhance revenue growth. Looking ahead, Vericel is guiding for approximately 20-23% revenue growth, supported by the positive momentum in MACI and the addition of NexoBrid to its portfolio, indicating a potential for profit inflection and favorable market conditions.

Bears say

Vericel Corp's financial performance shows signs of concern, as recent revenue results for both NexoBrid and Epicel fell short of expectations, indicating potential weaknesses in market demand. The company faced a top-line miss in its fourth quarter, reporting $75.4 million, which was beneath the anticipated range and highlights challenges in achieving growth in its critical product lines due to competitive pressures and market dynamics. Additionally, management noted that patient treatment conversions for Epicel were lower than expected, partially attributed to patient health issues, leading to a cautious outlook on future performance and profitability initiatives.

Vericel (VCEL) has been analyzed by 9 analysts, with a consensus rating of Strong Buy. 56% of analysts recommend a Strong Buy, 44% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Vericel and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Vericel (VCEL) Forecast

Analysts have given Vericel (VCEL) a Strong Buy based on their latest research and market trends.

According to 9 analysts, Vericel (VCEL) has a Strong Buy consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $53.44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $53.44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Vericel (VCEL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.